Literature DB >> 29217202

Cell-free production, purification and characterization of human mitochondrial ADP/ATP carriers.

Aleksandra Woznicka-Misaila1, Céline Juillan-Binard1, Delphine Baud1, Eva Pebay-Peyroula1, Stéphanie Ravaud2.   

Abstract

Mitochondrial Carriers (MCs) are responsible for fluent traffic of a variety of compounds that need to be shuttled via mitochondrial inner membranes to maintain cell metabolism. The ADP/ATP Carriers (AACs) are responsible for the import of ADP inside the mitochondria and the export of newly synthesized ATP. In human, four different AACs isoforms are described which are expressed in tissue-specific manner. They are involved in different genetic diseases and play a role in cancerogenesis. Up to now only the structures of the bovine (isoform 1) and yeast (isoforms 2 and 3) AAC have been determined in one particular conformation, obtained in complex with the CATR inhibitor. Herein, we report that full-length human ADP/ATP Carriers isoform 1 and 3 were successfully expressed in cell-free system and purified in milligram amounts in detergent-solubilized state. The proteins exhibited the expected secondary structure content. Thermostability profiles showing stabilization by the CATR inhibitor suggest that the carriers are well folded.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADP/ATP carrier; Cell-free protein expression; Crystallization; Membrane protein; Mitochondrial carriers; Thermostability

Mesh:

Substances:

Year:  2017        PMID: 29217202     DOI: 10.1016/j.pep.2017.11.008

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  1 in total

Review 1.  Strategies for Successful Over-Expression of Human Membrane Transport Systems Using Bacterial Hosts: Future Perspectives.

Authors:  Michele Galluccio; Lara Console; Lorena Pochini; Mariafrancesca Scalise; Nicola Giangregorio; Cesare Indiveri
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.